- Citations, last 5 years
- 39
- Works, last 5 years
- 5
- h-index
- 37
- Scientists listed
- 0
- Grants since 2016
- 50
Grants received
2016–2019 · research · R44
DEVELOPMENT OF TOPICAL ANTIVIRAL AGENTS FOR TREATING MOLLUSCUM CONTAGIOSUM
Richard W Scott · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2016–2017 · research · R43
DEVELOPMENT OF DRUGS THAT TARGET THE M2 PROTON CHANNEL FROM INFLUENZA A VIRUS
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2016–2019 · research · R44
DEVELOPMENT OF TOPICAL ANTIVIRAL AGENTS FOR TREATING MOLLUSCUM CONTAGIOSUM
Richard W Scott · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2016–2020 · research · R44
DEVELOPMENT OF TOPICAL ANTIVIRAL AGENTS FOR TREATING MOLLUSCUM CONTAGIOSUM
Richard W Scott · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2014–2022 · research · R44
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
Jay Edward Wrobel · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2014–2022 · research · R44
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
Jay Edward Wrobel · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2014–2023 · research · R44
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
Jay Edward Wrobel · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2011–2023 · research · R44
Riluzole Prodrugs for Melanoma and ALS
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2011–2021 · research · R44
Riluzole Prodrugs for Melanoma and ALS
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2011–2021 · research · R44
Riluzole Prodrugs for Melanoma and ALS
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
